The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types of ...
Morning Overview on MSN
CRISPR researchers revived an ancient gene that could block disease
Researchers have used CRISPR to switch back on a gene that vanished from the human lineage roughly 20 million years ago, reviving a natural defense against excess uric acid that our ancestors once ...
The CEMIP enzyme inhibits the growth of oligodendrocytes and may serve as a therapeutic target to boost myelin repair in MS, ...
Researchers have captured real-time "molecular movies" showing how an enzyme changes shape during catalysis. The study was ...
Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid (CSF), a prespecified ...
A decade ago, a group of scientists had the literally brilliant idea to use bioluminescent light to visualize brain activity.
Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...
RFdiffusion2, RFdiffusion3, and Riff-Diff each solve different structural problems in computational enzyme design ...
Like “Stranger Things” and “Harry Potter,” this horror film franchise is branching out with an original story that aims to pull the rug from under theatergoers. Like “Stranger Things” and “Harry ...
Roche Pharma Research and Early Development, Neuroscience and Rare Disease Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland Roche Pharma Research and Early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback